產(chǎn)品名稱 |
LASCPC-01 |
商品貨號 |
B161409 |
Organism |
Homo sapiens, human |
Tissue |
prostate |
Product Format |
frozen 1.0 mL |
Morphology |
aggregate |
Culture Properties |
suspension/aggregate |
Biosafety Level |
2 [Cells contain lentivirus genes]
Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country. |
Disease |
prostate cancer |
Age |
75-80 |
Gender |
male |
Ethnicity |
Caucasian |
Applications |
This cell line with the N-Myc as a
driver of NEPC can serve for studying therapeutic treatments of Neuroendocrine prostate cancer (NEPC) |
Karyotype |
Conventional karyotyping: normal 46 X,Y
Array CGH: mosaic gian of 1q23.1-1q44 |
Images |
|
Clinical Data |
75-80 years
male
Caucasian |
Comments |
Expression of RFP, GFP, MYCN, and myristoylated AKT1. |
Complete Growth Medium |
To prepare 500mL of complete medium:
- 464 mL Modified HITES medium (prepared as below)
- 1 mL Hydrocortisone (Sigma cat# H-0135; 10 nM or 1.0 x 10-8 M)
- 5 mL Transferrin (Sigma cat# T-5391; 0.01 mg/mL or 10 µg/mL)
- 25 mL FBS (ATCC 30-2020)
- 5 mL L-Glutamine (ATCC 30-2214)
Modified HITES Medium
- Insulin, human recombinant (Life Technologies cat# 12585-014), 50 mg
- Sodium Selenite (Sigma cat# S9133), 0.04326 mg
- Β-Estradiol (Sigma cat# E2257), 0.02724 mg
- L-Glutamine (ATCC 30-2214), 2.922 g
- RPMI-1640 (ATCC 30-2001), 10 L
Adjust pH to 7.2 – 7.4. Filter sterilize through a 0.2 micrometer filter, dispense 500 mL into 500 mL bottles.
Note: Complete culture medium is stable for 1 month once hydrocortisone and transferrin are added. |
Subculturing |
Cultures can be maintained by addition of fresh medium once or twice a week. |
Cryopreservation |
liquid nitrogen vapor phase |
Culture Conditions |
Atmosphere: air, 95%; carbon dioxide (CO2), 5%
Temperature: 37°C |
Cells per Vial |
Since being aggregates we use 20 ml culture medium with healthy aggregates per 1 ml freeze volume |
Volume |
1.0 mL |
STR Profile |
Amelogenin: X,Y
CSF1PO: 10,11
D13S317: 12
D16S539: 11
D5S818: 11
D7S820: 8,10
THO1: 9
TPOX: 8,11
vWA: 15,17 |
Sterility Tests |
Bacteria and yeast: No growth
Mycoplasma: No growth |
Viability |
≥ 50% |
Population Doubling Time |
Approximately 24 hours per depositor |
Name of Depositor |
J Lee |
Year of Origin |
2014 |
References |
Lee JK, et al. N-Myc drives neuroendocrine prostate cancer initiated from human prostate epithelial cells. Canc Cell 29(4):536-47, 2016. PubMed: 27050099
|